The expression of nectin-1, rather than deficiencies in the cellular antiviral mechanisms, is a critical determinant of tumor cell susceptibility to HSV-1 and may serve as a predictor of therapeutic efficacy (198). The gene discussed is NECTIN1; the disease is neoplasm.